Stanker James H 4/A
4/A · Processa Pharmaceuticals, Inc. · Filed Oct 5, 2022
Insider Transaction Report
Form 4/AAmended
Stanker James H
Chief Financial Officer
Transactions
- Award
Restricted Stock Units
2022-09-30−12,950→ 339,663 totalExercise: $0.00→ Common Stock (12,950 underlying)
Footnotes (2)
- [F1]Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death.
- [F2]Previous filing inadvertently underreported derivative securities beneficially owned by the reporting person.